Liam (Zhi Liang) Wei
About Liam (Zhi Liang) Wei
Liam (Zhi Liang) Wei is a Principal Scientist at Bristol Myers Squibb with over 15 years of experience in industrial drug discovery.
Current Role at Bristol Myers Squibb
Liam (Zhi Liang) Wei is currently serving as a Principal Scientist at Bristol Myers Squibb. His role involves leading various projects and initiatives in the realm of drug discovery and development. He focuses on optimizing small molecule therapeutics and collaborates extensively with internal teams and external partners to advance clinical candidates.
Previous Experience at MyoKardia
From 2018 to 2020, Liam Wei worked as a Senior Scientist at MyoKardia in South San Francisco, California. During this tenure, he contributed significantly to projects aimed at the discovery and development of novel therapeutic approaches for cardiovascular diseases.
Career at Synterys, Inc.
Liam Wei served as a Principal Scientist at Synterys, Inc. from 2010 to 2015 in Union City, CA. In this role, he spearheaded multiple drug discovery projects, focusing on structure-activity relationships and lead optimization. He also managed collaborations with Contract Research Organizations (CROs) and played a pivotal role in advancing clinical candidates.
Educational Background
Liam Wei earned his Ph.D. in Organic Chemistry from the Shanghai Institute of Organic Chemistry. His academic training laid a strong foundation for his expertise in medicinal chemistry, organic synthesis, route scouting, and process chemistry.
Publications and Research Contributions
Liam Wei has authored over 40 publications in the field of medicinal chemistry. His research contributions span multiple areas including cardiovascular, central nervous system, oncology, and metabolic diseases. His work has been instrumental in the development of numerous clinical candidates.